Cat. No.: X23-10-ZQ396
JAK inhibitor Momelotinib mesylate, Purity ≥98%
Synonym: momelotinib Mesylate; CYT387 Mesylate; 1056636-07-7; CYT387 (Mesylate); N-(Cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide; methanesulfonic acid; JAK inhibitor
- CAS Number: 1056636-07-7
- Compound CID: 78357762
Product Size
1 mg; 5 mg; 10 mg; 25 mg
Properties
Description
Momelotinib mesylate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and JAK3.
Molecular Formula
C24H26N6O5S
Targets
JAK1: 11 nM; JAK2: 18 nM; JAK3: 155 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Momelotinib mesylate can be applied to research inhibition of JAK1 and JAK2 signaling.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links